ISSN 1662-4009 (online)

ey0021.5-3 | Advances in Clinical Practice | ESPEYB21

5.3. The Global ALPL gene variant classification project: dedicated to deciphering variants

Farman Mariam R , Rehder Catherine , Malli Theodora , Rockman-Greenberg Cheryl , Dahir Kathryn , Angel Martos-Moreno Gabriel , Linglart Agnes , al. et

In brief: This article describes the functionalities of the Global ALPL gene variant classification project, which aims to reclassify variants of uncertain significance (VUS) in the ALPL gene and to continuously assess and update genetic, phenotypic, and functional variant information in hypophosphatasia.Commentary: Hypophosphatasia (HPP) is a rare genetic disorder caused by loss-of-function mutations in the alkaline phosphatase ( A...

ey0021.14-11 | Risk and Outcome | ESPEYB21

14.11. Gut bacteria convert glucocorticoids into progestins in the presence of hydrogen gas

McCurry Megan D. , D'Agostino Gabriel D. , Walsh Jasmine T. , Turnbaugh Peter J. , Huh Jun R. , Devlin A. Sloan

Brief Summary:This study using mice and human models, shows that human gut bacteria Gordonibacter pamelaeae and Eggerthella lenta convert biliary corticoids into progestins through 21-dehydroxylation. It thereby shows that a class of immuno- and metabo-regulatory steroids are transformed into a class of sex hormones and neurosteroids. It also illustrates that gut hydrogen gas production is essential and sufficient to support this metabolic pathway, which is m...

ey0021.5-2 | Advances in Clinical Practice | ESPEYB21

5.2. Clinical profiles of children with hypophosphatasia prior to treatment with enzyme replacement therapy: an observational analysis from the global HPP registry

Martos-Moreno Gabriel Angel , Rockman-Greenberg Cheryl , Ozono Keiichi , Petryk Anna , Kishnani Priya S. , Dahir Kathryn M. , Seefried Lothar , Fang Shona , Hogler Wolfgang , Linglart Agnes

In brief: This observational analysis, based on data from the Global Hypophosphatasia Registry, reports the clinical profiles, prior to initiation of asfotase alfa enzyme replacement therapy, in a large cohort of children with hypophosphatasia (n=151), by age (<6 months vs 6 months to 18 years) and geographic region (USA/Canada, Europe, and Japan).Commentary: Hypophosphatasia (HPP) is a rare genetic disorder caused by loss-of-function mutations in th...

ey0016.15-10 | (1) | ESPEYB16

15.10. Growth hormone regulates neuroendocrine responses to weight loss via AgRP neurons

Furigo Isadora C , Teixeira Pryscila DS , de Souza Gabriel O , Couto Gisele CL , Romero Guadalupe Garcia , Perello Mario , Frazao Renata , Elias Lucila L , Metzger Martin , List Edward O , Kopchick John J , Donato J

To read the full abstract: Nature Communications, 2019; 10 (1); 662This paper highlights the brain as a key target for growth hormone (GH) signaling affecting mostly energy conservation. To identify GH response neurons, C57BL/6 mice received intraperitoneal injection of saline or GH and their brains were processed to detect the phosphorylation of pSTAT5 as a marker of GH receptor a...